Waters Corporation
WATDiagnostics & Research
$462.72−3.61%As of Oct 30vs prior close
- Market cap
- $45.4B
- P/E (TTM)
- 42.8×
- P/E (FY1)
- 31.7×
- Implied growth
- 28.7%
- From 52W high
- −3.61%
- EPS (LTM)
- $10.76
- Revenue (LTM)
- $3.2B
- Net margin
- 20.30%
- Dividend yield
- 0.00%
Nomior Score
67
Fortified DefenderTop 13% of the scored universe
Growth47
Quality74
Value47
Momentum70
Resilience66
Growth
+4.30%revenue a year over 9 fiscal years
YE16 $2.2BLTM $3.2B
Connections
Revenue to profitQ2 YE26
The operating loss was 5% of revenue, wider by 30 pts on a year.
Who owns it
7funds, 8 tracked portfolios